Talk Presenting Companies (Theatre B) track
Drug Discovery and Development: 3billion
Mon, Nov 9, 2026 · 3:15–3:30 PM CET Koelnmesse
About this session
3billion is a global leader in AI-powered rare disease diagnostics, with a CAP/CLIA-accredited laboratory and proprietary AI variant interpretation system (GEBRA™). We deliver highly accurate genetic testing (3B-EXOME and 3B-GENOME) for rare disease patients, analyzing millions of variants with 99.4% accuracy in under 5 minutes. To date, we have supported over 100,000 patients across 70+ countries and 790+ institutions, creating one of the world's largest proprietary datasets combining genomic and real-world phenotypic data.
Speaker
-
Chief Business Development Officer · 3billion
Speaker